Pacific Biosciences
PACB
#7744
Rank
A$0.60 B
Marketcap
A$1.95
Share price
-2.50%
Change (1 day)
-23.69%
Change (1 year)

Pacific Biosciences (PACB) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$1.11 Billion

According to Pacific Biosciences 's latest financial reports the company's total liabilities are A$1.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Pacific Biosciences - Total liabilities on balance sheet (from 2009 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$1.16 B-4.07%
2024-12-31A$1.21 B-20.96%
2023-12-31A$1.53 B-13.34%
2022-12-31A$1.76 B5.5%
2021-12-31A$1.67 B1543.16%
2020-12-31A$0.10 B-23.21%
2019-12-31A$0.13 B66.58%
2018-12-31A$79.79 M7.44%
2017-12-31A$74.26 M0.6%
2016-12-31A$73.82 M-6.57%
2015-12-31A$79.02 M-6.87%
2014-12-31A$84.84 M12.95%
2013-12-31A$75.11 M284.53%
2012-12-31A$19.53 M-25.41%
2011-12-31A$26.18 M2.79%
2010-12-31A$25.47 M-91.77%
2009-12-31A$0.30 B5.82%
2008-12-31A$0.29 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
A$87.67 B 7,748.73%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$157.25 B 13,977.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$5.56 B 397.82%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
A$9.45 B 746.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
A$0.46 B-58.30%๐Ÿ‡บ๐Ÿ‡ธ USA